Dg Health Miconazole 3 Kit
Product Images NDC 55910-081

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dg Health Miconazole 3 (NDC 55910-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dolgencorp Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Miconazole Image 1 (Image 01)

FDA Label Image

Miconazole Image 2 (Image 02)

FDA Label Image

Miconazole Image 3 (Image 03)

FDA Label Image

Miconazole Image 4 (Image 04)

FDA Label Image

Miconazole Image 5 (Image 05)

FDA Label Image

Image 06

Image 06
DG |health offers a 3-Day Treatment for Vaginal Yeast Infections, which includes a pack of 3 Miconazole Nitrate Vaginal Suppositories (200mg) and Miconazole Nitrate Vaginal Cream (2%) along with external vulvar cream. The combination pack helps to cure most vaginal yeast infections and relieve associated external itching and irritation. The pack includes disposable applicators and a tube containing 2.5 g of each suppository, and a 9g tube of external cream. The product is distributed by Old Eastmain Co. and is guaranteed by 100 Missionridge, Goodlettsville, TN 37072.*
FDA Label Image

Image 07

Image 07
This is a medication warning label about a suppository product for vaginal use. The label provides guidance on the active ingredients, dosages, and usage instructions. It warns users not to use the product if the printed wrapper is missing or damaged and not to use if pregnant, breastfeeding, or under 12 years old without consulting a doctor or pharmacist. The label also cautions against using other vaginal products and advises that condoms and diaphragms may be damaged while using the product. The user is encouraged to seek medical attention if symptoms persist or worsen after three days or if any unusual symptoms occur, including rash, hive, fever, chills, nausea, vomiting, or unusual vaginal discharge.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.